SHUKUR, H. Y. Long term continuous Trastuzumab use for HER2-positive advanced breast cancer. Journal of Contemporary Medical Sciences, [S. l.], v. 6, n. 5, p. 234–241, 2020. DOI: 10.22317/jcms.v6i5.862. Disponível em: https://jocms.org/index.php/jcms/article/view/862. Acesso em: 25 apr. 2024.